PKD2 and autosomal dominant polycystic kidney disease: We analyzed publicly available Pkd2 KO mouse RNA-Seq data sets to assess differential gene expression, pathway enrichment, and transcriptomic signature reversion to identify potential drug repurposing candidates to identify prioritized therapeutics for the ADPKD community.